|
For the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection. This is a lyophilized recombinant canarypox vectored West Nile Virus vaccine plus a sterile liquid diluent. A canary pox vector has been modified using recombinant technology to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation. the vector does not multiply in the horse. but does express the protective proteins. As a consequence. these components induce an immune status against West Nile Virus. Safety and immunogenicity of this vaccine have been demonstrated by vaccination and challenge tests in susceptible horses. Packaged in a 10ds flat. DOSAGE: reconstitute the lyophilized vaccine with the accompanying liquid diluent and aseptically inject 1 ml dose by intramuscular route. For primary vaccination. revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended. Do not vaccinate 21 days prior to slaughter. Sold in packages of 10 doses only.
Requires cold packaging.
Merial
|
Poultry
